| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Gowri Sivaramakrishnan | Q55755045 |
| P2093 | author name string | Kannan Sridharan | |
| P2860 | cites work | Terlipressin for hepatorenal syndrome | Q24200336 |
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| A Multiple Testing Procedure for Clinical Trials | Q28248823 | ||
| Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study | Q33966802 | ||
| Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. | Q34011626 | ||
| Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites | Q34062056 | ||
| Hepatorenal syndrome: pathophysiology and management. | Q34663344 | ||
| Hepatorenal syndrome. Definition, pathophysiology, and intervention | Q34675396 | ||
| Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis | Q35244409 | ||
| Noradrenalin versus the combination of midodrine and octreotide in patients with hepatorenal syndrome: randomized clinical trial. | Q36422621 | ||
| Meta-analysis: terlipressin therapy for the hepatorenal syndrome | Q36583826 | ||
| Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis | Q36772257 | ||
| A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome | Q37061659 | ||
| EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis | Q37773059 | ||
| Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome | Q38439344 | ||
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations | Q38510678 | ||
| The attractiveness of network meta-analysis: a comprehensive systematic and narrative review | Q38544308 | ||
| Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options | Q38654403 | ||
| Hepatorenal syndrome: outcome of response to therapy and predictors of survival | Q40380997 | ||
| Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study. | Q41056258 | ||
| Prognostic significance of renal dysfunction in cirrhosis. | Q41610481 | ||
| Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial | Q44287768 | ||
| Effect of terlipressin on blood volume distribution in patients with cirrhosis | Q44923565 | ||
| Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study | Q45003218 | ||
| Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. | Q45027863 | ||
| An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response | Q46537222 | ||
| Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. | Q46948629 | ||
| Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study. | Q51059723 | ||
| Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial | Q56969064 | ||
| How to read a funnel plot in a meta-analysis | Q61312392 | ||
| Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study | Q83417247 | ||
| Hepatorenal syndrome, pharmacological therapy, and liver transplantation | Q84965903 | ||
| P433 | issue | 1 | |
| P921 | main subject | hepatorenal syndrome | Q247131 |
| P304 | page(s) | 97-102 | |
| P577 | publication date | 2017-09-18 | |
| P1433 | published in | Journal of General Internal Medicine | Q6295242 |
| P1476 | title | Vasoactive Agents for Hepatorenal Syndrome: A Mixed Treatment Comparison Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials | |
| P478 | volume | 33 |
| Q49885797 | Botulinum Toxin for Refractory Trigeminal Neuralgia: A Trial Sequential Analysis of Randomized Clinical Trials. |
| Q51730524 | Fluoride varnish versus glutaraldehyde for hypersensitive teeth: a randomized controlled trial, meta-analysis and trial sequential analysis. |
| Q58798112 | High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome |
Search more.